Rather than financing receivables and assuming the risk
for bad debts, why not accept credit card payments?
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
="_new" href="http://www.yenommarketinginc.com/creditcards.html">http://www.yenommarketinginc.com/creditcards.html
3. Drop Ship Products
Rather than financing and stocking invent
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ry yourself,
consider drop shipping.
With drop shipping, when you make a sale you contact
the manufacturer or authorized distributor who ships
the product to the customer with y
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
.yenommarketinginc.com/dropship.html">http://www.yenommarketinginc.com/dropship.html
4. Use Your Customer`s Money
Selling memberships, subscriptions, gift certificates,
and cou
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
pon books are just a few ways of getting your
clients to pay upfront. Obtaining advance deposits
and retainers from your customers can help finance your
business operations and
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
educe or eliminate the need
for bank financing.
5. Licensing
Instead of trying to finance the manufacturing and
marketing of your invention, which could cost millions
of dollar
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
before you have your first sale, why not license it
to a company with the necessary expertise and capital?
You will then receive royalties in return for your idea.
For more infor
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
s
Aggressively control costs, barter, get extended terms from
suppliers, establish strict credit and collection policies
and procedures, rent (or lease) instead of buying equipment
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
,
buy used equipment instead of new, sell off excess inventory
and equipment, obtain free publicity instead of paying for
advertising, and do whatever else is necessary to generat
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
cashflow and profits.
In these ways and many others not listed here, you may be
able to start and grow your business successfully with very
limited capital. Thus, you will avo
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
d having to obtain
expensive debt or equity financing.
Many who were unable to obtain financing from any other source
have successfully bootstrapped their way to business success.
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products